Cumulative incidence in competing risks data and competing risks regression analysis.
about
Traumatic brain injury and risk of dementia in older veteransChanges in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gapBreast cancer risk is increased in the years following false-positive breast cancer screeningInflammatory status and lung function predict mortality in lung cancer screening participants.Understanding competing risks: a simulation point of viewA Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study.Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland.Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyCompeting risk of death: an important consideration in studies of older adults.Prospective cohort study of fever incidence and risk in elderly persons living at home.Proximal femoral replacement in the management of acute periprosthetic fractures of the hip: a competing risks survival analysisPrediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia.An updated natural history model of cervical cancer: derivation of model parameters.SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis.Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Hyponatremia as a predictor of mortality in peritoneal dialysis patients.Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.Young aboriginals are less likely to receive a renal transplant: a Canadian national study.Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.Loss to follow-up as a competing risk in an observational study of HIV-1 incidenceModelling competing risks in nephrology research: an example in peritoneal dialysis.The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinicsUbiquitous burden: the contribution of migration to AIDS and Tuberculosis mortality in rural South Africa.Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer5-year survival and rehospitalization due to stroke recurrence among patients with hemorrhagic or ischemic strokes in SingaporeTemporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005.Analysis and design of randomised clinical trials involving competing risks endpointsImpact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.Checking Fine and Gray subdistribution hazards model with cumulative sums of residualsMeasures of survival benefit in cancer drug development and their limitations.Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Total Femur Replacement After Tumor Resection: Limb Salvage Usually Achieved But Complications and Failures are CommonTen-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCISThe use and interpretation of competing risks regression modelsImproved Method to Stratify Elderly Patients With Cancer at Risk for Competing EventsAbsolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia
P2860
Q28391306-71366C39-B174-446B-94E6-035E6908EB5BQ28476575-99741055-5ED8-4D2E-A238-B3B9659CCF2DQ30490199-10BCD1C0-ED7D-47CB-8B2F-9631B3CF7471Q30491209-15BB65C9-FE1A-48BB-AF9B-E01EF572106BQ31015561-DE9EC7F8-2F92-4468-A88D-6641CB71475DQ31066319-B7939D06-70C1-40E1-B757-ED658A410CC9Q33379538-72A8B71E-5A25-4D2C-B691-DE02ABEC90FBQ33551400-D3C994A9-F126-40D4-889E-73346A9226BAQ33571802-7A1255BC-EA8A-45DA-B012-357A94D70FA8Q33707461-A4403EA4-DB39-4008-BE40-739999E0F622Q33862367-9773C9DA-B4F6-4EFE-A8F1-C12D220944D6Q33879835-1E502B01-6A6A-45D5-A061-F3D6BE7B692BQ33895785-2F173CEA-556D-4FDC-A16D-A7C5E5A03A18Q34055676-BDB78B72-AE0E-4A49-86DA-B7FBA7C67C2CQ34083083-5B9195EA-AD33-4FAF-B74E-91E4F70B459BQ34226368-A5E5DA0F-EDBA-45EC-8AED-D9473D2CF997Q34273563-5CEF58A5-BBC0-4438-93BB-37CF98E35722Q34285987-273546BC-5EC0-441E-B69D-BCAFA1219204Q34343656-92FD75BA-727F-486F-9960-2C5970F78B03Q34420998-4E7C26F3-362E-46C0-8E4E-9D603DEAC338Q34424834-8E8AA712-E29A-4D10-87D6-4659CFCF0941Q34547503-12E78BDC-A701-4C7E-92C7-57069A339B3AQ34630887-D04E5067-E915-4765-BFC2-CBDA94F260B8Q34649232-A58A5756-D85E-4FD5-8F8C-AD9AB8168165Q34738940-54C5D433-5894-4B05-9A0A-F81F1E6478F9Q34802051-388E0261-4818-431A-84B9-8CAC21C059CBQ34845395-92AA26DF-8139-4B27-90A3-53827C6236C8Q35002416-633AE1A7-D392-4DCF-9F19-09F960BDF5F8Q35006790-B939ADFD-6E48-47AC-AAB8-1BD0FBEEC705Q35060122-C991CB5E-8311-4CDD-B84F-0C0CCC97B4A8Q35089188-8F4DD419-7BCA-4346-8BF2-542B27ED98E8Q35167738-AB209D52-20E4-466F-B35B-D226AD246340Q35283147-74FCDB75-83B0-446E-83AD-B703A36E479CQ35490675-C1D28B19-673F-406A-9E37-F0184B093569Q35495340-47920FD6-C88E-4715-93FE-BFD7C92F18F7Q35567505-E43D1197-C128-40E0-9FC4-A591F7C71577Q35894357-F27FBA02-76BA-48A0-AC63-8B60894E63D3Q35894830-BBA008A1-6916-4D66-B7E7-44E5BA3ABDF5Q35925651-F496DA16-27FA-4783-A061-E6433F2FDD5FQ35955272-85CAEBA7-1AEC-450C-8065-FBC437DEA3C7
P2860
Cumulative incidence in competing risks data and competing risks regression analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cumulative incidence in competing risks data and competing risks regression analysis.
@ast
Cumulative incidence in competing risks data and competing risks regression analysis.
@en
type
label
Cumulative incidence in competing risks data and competing risks regression analysis.
@ast
Cumulative incidence in competing risks data and competing risks regression analysis.
@en
prefLabel
Cumulative incidence in competing risks data and competing risks regression analysis.
@ast
Cumulative incidence in competing risks data and competing risks regression analysis.
@en
P1476
Cumulative incidence in competing risks data and competing risks regression analysis.
@en
P2093
Haesook T Kim
P304
P356
10.1158/1078-0432.CCR-06-1210
P407
P433
P577
2007-01-01T00:00:00Z